Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Kiox Pharmaceuticals ApS
APS
Active
CVR 42886866
Stolbjergvej 26C
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2021
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -412K
-200% vs 2023
EBITDA margin
586.0%
-95% vs 2023
Equity ratio
30.0%
Financial strength
Net profit 2024
DKK -1,8M
-90% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2022
-1M
-100%
2023
-2M
-100%
2024
Key figures
Annual report 2024
Revenue
DKK -412K
-200%
EBITDA
DKK -2,4M
-95%
Net profit
DKK -1,8M
-90%
Total assets
DKK 784K
-3%
Equity
DKK 235K
+468%
Employees
—
—
Company information
Legal name
Kiox Pharmaceuticals ApS
CVR number
42886866
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
7. december 2021
Share capital
DKK 308.898
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Stolbjergvej 26C
Email
info@kioxpharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Helsingør
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2022
-1M
2023
-2M
2024
Income statement
DKK thousands
Item
2022
2023
2024
Revenue
-3
412
-412
Staff expenses
-0
-0
-0
EBITDA
-3
-1.239
-2.413
Depreciation & amort.
-0
-0
-0
EBIT
-3
-1.239
-2.413
Net financials
-0
-3
27
Profit before tax
-3
-1.242
-2.386
Tax
-0
-273
-545
Net profit
-3
-969
-1.841
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
37
805
784
Equity
37
-64
235
Long-term debt
0
0
0
Short-term debt
0
869
549
Total debt
0
869
549
Financial ratios
5-year trend
EBITDA margin
-241313400.0%
This company
15.8%
Market median
-1527300100% vs market
2022
2024
Equity ratio
30.0%
This company
38.2%
Market median
-21% vs market
2022
2024
Return on equity
-782.9%
This company
18.4%
Market median
-4355% vs market
2022
2024
Net profit margin
-184103000.0%
This company
8.1%
Market median
-2272876643% vs market
2022
2024
Asset turnover
-0.52×
This company
1.12×
Market median
-146% vs market
2022
2024
Debt / equity
2.34×
This company
0.62×
Market median
-277% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-12-07 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
TD
Tim Dehli Carstensen
Management
Management
2024
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
MW
Mikkel Walmar
Chairman
2026
—
—
IT
Inge Tarnow
Board of Directors
2026
—
—
LH
Lars Hellerung Christiansen
Board of Directors
2026
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
26c Holding ApS
Company
66.7%
66.7%
2024
Titi14 HOLDING ApS
Company
20.0%
20.0%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Titi14 HOLDING ApS
Kiox Pharmaceuticals ApS
(this company)
Board network connections
Board members of Kiox Pharmaceuticals ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Tim Dehli Carstensen
Management
0 companies
Mikkel Walmar
Chairman
0 companies
Inge Tarnow
Board of Directors
0 companies
Lars Hellerung Christiansen
Board of Directors
0 companies